Handok Inc. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
327,936
348,311
358,448
396,134
417,970
446,731
Cost of Goods Sold (COGS) incl. D&A
233,935
241,355
246,566
277,891
297,191
301,666
Gross Income
94,002
106,956
111,882
118,243
120,779
145,065
SG&A Expense
86,548
96,641
105,661
114,603
122,819
123,159
EBIT
7,454
10,315
6,221
3,640
2,040
21,906
Unusual Expense
1,911
6,237
1,451
100
2,552
867
Non Operating Income/Expense
11,632
2,292
5,283
3,525
39,151
9,474
Interest Expense
1,814
2,904
2,740
3,099
5,223
5,865
Pretax Income
19,189
11,447
7,349
4,034
6,696
9,344
Income Tax
3,214
2,182
1,085
2,374
3,243
2,282
Equity in Affiliates
3,666
7,792
8,066
13,809
-
-
Consolidated Net Income
12,310
1,473
1,803
7,401
3,453
7,063
Net Income
12,310
1,473
1,687
6,454
4,869
7,990
Net Income After Extraordinaries
12,310
1,473
1,687
6,454
4,869
7,990
Net Income Available to Common
12,310
1,473
1,687
6,454
4,869
7,990
EPS (Basic)
1,050.04
121.00
136.00
518.00
391.00
589.77
Basic Shares Outstanding
12
12
12
12
12
14
EPS (Diluted)
1,050.20
121.48
135.54
518.49
390.45
589.07
Diluted Shares Outstanding
12
12
12
12
12
14
EBITDA
18,521
23,390
20,392
18,429
15,615
41,816
Non-Operating Interest Income
6
91
36
67
125
588
Minority Interest Expense
-
-
116
947
1,415
927
Equity in Affiliates (Pretax)
-
-
-
-
22,766
15,892

About Handok

View Profile
Address
132 Teheran-ro
Seoul SL 06235
Korea, Republic Of
Employees -
Website http://www.handok.co.kr
Updated 07/08/2019
Handok, Inc. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Medicine, Medical Device, Healthcare Product, Rental, and Gene Analysis. The Medicine business offers ETC and OTC medicines.